About Newronika
Newronika is a company based in Cologno Monzese (Italy) founded in 2016 by Alberto Priori.. Newronika has raised $25.24 million across 5 funding rounds from investors including Intesa Sanpaolo, European Union and ENEA Tech e Biomedical. Newronika offers products and services including AlphaDBS, FilterDBS, and WebBioBank. Newronika operates in a competitive market with competitors including NovaVision, MindAffect, EnClear Therapies, Actipulse Neuroscience and AccuMedical, among others.
- Headquarter Cologno Monzese, Italy
- Founders Alberto Priori
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Newronika S.P.A.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25.24 M (USD)
in 5 rounds
-
Latest Funding Round
$14.11 M (USD), Series B
Feb 13, 2025
-
Investors
Intesa Sanpaolo
& 10 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Newronika
Newronika offers a comprehensive portfolio of products and services, including AlphaDBS, FilterDBS, and WebBioBank. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Adaptive implant for real-time brain stimulation adjustment.
Records noise-free brain signals during stimulation.
Cloud platform for collecting and analyzing biosignal data.
Unlock access to complete
Clinical Team
1 people
Firmware Team
1 people
Software Development Team
1 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Newronika
Newronika has successfully raised a total of $25.24M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $14.11 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $14.1M
-
First Round
First Round
(15 Jun 2016)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series B - Newronika | Valuation | ENEA Tech e Biomedical | |
| Mar, 2023 | Amount | Grant - Newronika | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - Newronika | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Newronika
Newronika has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Intesa Sanpaolo, European Union and ENEA Tech e Biomedical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are managed by Indaco in Italy.
|
Founded Year | Domain | Location | |
|
VC firm investing in seed and early stage companies in Italy
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Newronika
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Newronika
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Newronika Comparisons
Competitors of Newronika
Newronika operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NovaVision, MindAffect, EnClear Therapies, Actipulse Neuroscience and AccuMedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Non-invasive devices are developed for vision restoration in stroke survivors.
|
|
| domain | founded_year | HQ Location |
Brain-computer interface headsets are developed for patient communication.
|
|
| domain | founded_year | HQ Location |
Developer of device-based therapies to treat neurodegenerative disorders
|
|
| domain | founded_year | HQ Location |
Non-invasive brain stimulation technology is developed for neurodegenerative disorders.
|
|
| domain | founded_year | HQ Location |
Neurovascular interventional devices for neurological disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Newronika
Frequently Asked Questions about Newronika
When was Newronika founded?
Newronika was founded in 2016.
Where is Newronika located?
Newronika is headquartered in Cologno Monzese, Italy. It is registered at Cologno Monzese, Lombardy, Italy.
Who is the current CEO of Newronika?
Lorenzo Rossi is the current CEO of Newronika.
Is Newronika a funded company?
Newronika is a funded company, having raised a total of $25.24M across 5 funding rounds to date. The company's 1st funding round was a Grant of $434.29K, raised on Jun 15, 2016.
What does Newronika do?
Newronika was founded in 2016 in Cologno Monzese, Italy, within the medical technology sector. Devices addressing neurodegenerative diseases are created, including AlphaDBS, a closed-loop deep brain neuromodulation system designed to interpret bioelectrical neuronal activity. WebBioBank, a web-based platform, is employed by researchers for collecting, analyzing, and interpreting biosignals alongside electronic health records from patients in neuromodulation treatments. Operations center on advancing therapeutic tools for neurological conditions.
Who are the top competitors of Newronika?
Newronika's top competitors include NovaVision, Actipulse Neuroscience and EnClear Therapies.
What products or services does Newronika offer?
Newronika offers AlphaDBS, FilterDBS, and WebBioBank.
Who are Newronika's investors?
Newronika has 11 investors. Key investors include Intesa Sanpaolo, European Union, ENEA Tech e Biomedical, Indaco Venture Partners, and Innogest Capital.